Toggle Main Menu Toggle Search

Open Access padlockePrints

A pilot study of a ketogenic diet in bipolar disorder: clinical, metabolic and magnetic resonance spectroscopy findings

Lookup NU author(s): Dr Benjamin RigbyORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Background: Preliminary evidence suggests that a ketogenic diet may be effective for bipolar disorder. Aims: To assess the impact of a ketogenic diet in bipolar disorder on clinical, metabolic and magnetic resonance spectroscopy outcomes. Method: Euthymic individuals with bipolar disorder (N = 27) were recruited to a 6- to 8-week single-arm open pilot study of a modified ketogenic diet. Clinical, metabolic and MRS measures were assessed before and after the intervention. Results: Of 27 recruited participants, 26 began and 20 completed the ketogenic diet. For participants completing the intervention, mean body weight fell by 4.2 kg (P < 0.001), mean body mass index fell by 1.5 kg/m2 (P < 0.001) and mean systolic blood pressure fell by 7.4 mmHg (P < 0.041). The euthymic participants had average baseline and follow-up assessments consistent with them being in the euthymic range with no statistically significant changes in Affective Lability Scale-18, Beck Depression Inventory and Young Mania Rating Scale. In participants providing reliable daily ecological momentary assessment data (n = 14), there was a positive correlation between daily ketone levels and self-rated mood (r = 0.21, P < 0.001) and energy (r = 0.19 P < 0.001), and an inverse correlation between ketone levels and both impulsivity (r = −0.30, P < 0.001) and anxiety (r = −0.19, P < 0.001). From the MRS measurements, brain glutamate plus glutamine concentration decreased by 11.6% in the anterior cingulate cortex (P = 0.025) and fell by 13.6% in the posterior cingulate cortex (P = <0.001). Conclusions: These findings suggest that a ketogenic diet may be clinically useful in bipolar disorder, for both mental health and metabolic outcomes. Replication and randomised controlled trials are now warranted.Bipolar disorderketogenic dietketosismagnetic resonance spectroscopymetabolic psychiatry


Publication metadata

Author(s): Campbell IH, Needham N, Grossi H, Kamenska I, Luz S, Sheehan S, Thompson G, Thrippleton MJ, Gibbs MC, Leitao J, Moses T, Burgess K, Rigby BP, Simpson SA, McIntosh E, Brown R, Meadowcroft B, Creasy F, Mitchell-Grigorjeva M, Norrie J, McLellan A, Fisher C, Zielinksi T, Gaggioni G, Campbell H, Smith DJ

Publication type: Article

Publication status: Published

Journal: BJPysch Open

Year: 2025

Volume: 11

Issue: 2

Print publication date: 01/03/2025

Online publication date: 25/02/2025

Acceptance date: 16/11/2024

Date deposited: 13/03/2025

ISSN (electronic): 2056-4724

Publisher: Cambridge University Press

URL: https://doi.org/10.1192/bjo.2024.841

DOI: 10.1192/bjo.2024.841

Data Access Statement: The data that support the findings of this study are not publicly available as explicit consent was not sought from participants.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Baszucki Brain Research Fund
Scottish Chief Scientist Office through the NHS Lothian Research and Development Office

Share